<DOC>
	<DOC>NCT01373866</DOC>
	<brief_summary>- The efficacy of neuro-navigated rTMS for patients with schizophrenia suffering from drug-resistant multisensory hallucinations will be tested by the implementation of a double-blind randomized controlled trial (RCT) - This study will use a combination of different MRI modalities (fMRI and DTI) to define with precision rTMS brain-targets in the case of multisensory hallucinations - The investigators anticipate that multimodal MRI-guided rTMS will allow a significant improvement in the efficacy of neuromodulation treatment of refractory hallucinations</brief_summary>
	<brief_title>Multimodal MRI-guided rTMS to Treat Refractory Hallucinations</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Hallucinations</mesh_term>
	<mesh_term>Perceptual Disorders</mesh_term>
	<criteria>Righthanded Female/Male, [1360 y.o.], Schizophrenia (DSMIVTR diagnosis), Drugresistant hallucinations (Kinon &amp; Kane criteria, 1993), Unmodified antipsychotic dosage during the 30 days preceding rMTS, No anticonvulsive medication, No neurological disorder, no addictive behavior, Matched for sex, age and PANSS scores, Consent to participate to the study, Pregnancy Contraindication to MRI scan Contraindication to rTMS treatment Claustrophobia No social insurance</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Repetitive Transcranial Magnetic Stimulation</keyword>
	<keyword>Neuronavigation</keyword>
	<keyword>Functional Magnetic Resonance Imaging</keyword>
	<keyword>Diffusion Tensor Imaging</keyword>
</DOC>